Treatment of newly diagnosed metastatic
โ
Gerald P. Murphy; Sunmolu Beckley; Mark F. Brady; T. Ming Chu; Jean B. Dekernion
๐
Article
๐
1983
๐
John Wiley and Sons
๐
English
โ 699 KB
by the National Prostatic Cancer Project randomized newly diagnosed metastatic prostate cancer patients to DES 1 mg orally three times daily or orchiectomy; or DES, 1 mg, three times daily, plus cyclophosphamide at 1 mg/m2 iv every three weeks, or cyclophosphamide 1 g/m2 iv every three weeks plus es